Samantha Ruth Prabhu Denies Taking Rs. 25 Cr As Financial Help From Telugu Superstar For Myositis Treatment
Samantha was diagnosed with an auto -immune condition called myositis in 2022.
New Delhi: Samantha Ruth Prabhu is currently on 1 year break for her treatment of auto-immune condition myositis. Recently, the Telugu actor has been treating her fans from pictures from Bali, holidaying and enjoying her sabbatical. Samantha, who recently completed shooting for the Indian version of 'Citadel', is on a year-long break. Now, reports have begun springing about her taking Rs. 25 cr as financial help to get treatment for her condition. However, Samantha has quashed such rumours and clarified that she is perfectly capable of taking care of herself.
Samantha further shared that she can take care of herself after having worked for so long in films. She even asked the media to be responsible. Taking to her Instagram stories, Samantha wrote, " ₹25 crore to treat Myositis!? Someone got you a pretty bad deal. I am glad I am only spending the smallest fraction of that. And, I don’t think I was paid in marbles for all the work I’ve done in my career. So, I can easily take care of myself. Thank you. Myosotis is a condition thousands suffer from. Let’s please be responsible with the information we put out regarding the treatment.”
Samantha was diagnosed with an auto -immune condition called myositis in 2022. Samantha had taken a long treatment and gone to the USA for treatment. As per reports last year, Samantha had also spent a lot of money on her rare condition.
As per a Sakshi TV video report, Samantha had borrowed some Rs. 25 cr from a famous actor. However, the actor's identity was not revealed.
Samantha Ruth Prabhu upcoming movies and TV shows
Samantha Ruth Prabhu will be seen with Vijay Deverakonda in 'Kushi', a romantic film, which has been keeping fans brimming with excitement. Samantha also has 'Citadel' ( India version) which has been directed by Raj & DK, teh director duo who worked with Samantha in 'The Family Man' as well.